India·Source-based summary
SAT Hospital in Keralam rejects charges of‘clinical trial drugs’ given to SMA-afflicted children
Hospital Superintendent says decision to provide SMA patients with a less expensive, generic version of the original molecule against SMA, in place of the imported original drug costing several lakhs of rupees for a single vial, was taken by a technical committee comprising exper
This is a source-based summary, not original reporting by Ebenezer journalists. Source: The Hindu. Ebenezer published 22 Oct 2026, 04:33 pm. Editorial policy.
Read the original report on The Hindu →
India — The Hindu